HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sodium nitrite therapy attenuates the hypertensive effects of HBOC-201 via nitrite reduction.

Abstract
Hypertension secondary to scavenging of NO remains a limitation in the use of HBOCs (haemoglobin-based oxygen carriers). Recent studies suggest that nitrite reduction to NO by deoxyhaemoglobin supports NO signalling. In the present study we tested whether nitrite would attenuate HBOC-mediated hypertension using HBOC-201 (Biopure), a bovine cross-linked, low-oxygen-affinity haemoglobin. In a similar way to unmodified haemoglobin, deoxygenated HBOC-201 reduced nitrite to NO with rates directly proportional to the extent of deoxygenation. The functional importance of HBOC-201-dependent nitrite reduction was demonstrated using isolated aortic rings and a murine model of trauma, haemorrhage and resuscitation. In the former, HBOC-201 inhibited NO-donor and nitrite-dependent vasodilation when oxygenated. However, deoxygenated HBOC-201 failed to affect nitrite-dependent vasodilation but still inhibited NO-donor dependent vasodilation, consistent with a model in which nitrite-reduction by deoxyHBOC-201 counters NO scavenging. Finally, resuscitation using HBOC-201, after trauma and haemorrhage, resulted in mild hypertension ( approximately 5-10 mmHg). Administration of a single bolus nitrite (30-100 nmol) at the onset of HBOC-201 resuscitation prevented hypertension. Nitrite had no effect on mean arterial pressure during resuscitation with LR (lactated Ringer's solution), suggesting a role for nitrite-HBOC reactions in attenuating HBOC-mediated hypertension. Taken together these data support the concept that nitrite can be used as an adjunct therapy to prevent HBOC-dependent hypertension.
AuthorsCilina Rodriguez, Dario A Vitturi, Jin He, Marianne Vandromme, Angela Brandon, Anne Hutchings, Loring W Rue 3rd, Jeffrey D Kerby, Rakesh P Patel
JournalThe Biochemical journal (Biochem J) Vol. 422 Issue 3 Pg. 423-32 (Aug 27 2009) ISSN: 1470-8728 [Electronic] England
PMID19555351 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antihypertensive Agents
  • Blood Substitutes
  • Hemoglobins
  • Nitric Oxide Donors
  • HBOC 201
  • Nitric Oxide
  • deoxyhemoglobin
  • Nitrite Reductases
  • Sodium Nitrite
Topics
  • Animals
  • Antihypertensive Agents (pharmacology, therapeutic use)
  • Aorta (drug effects)
  • Blood Substitutes (metabolism, pharmacology)
  • Disease Models, Animal
  • Hemoglobins (metabolism, pharmacology)
  • Hypertension (drug therapy)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide (metabolism)
  • Nitric Oxide Donors (pharmacology)
  • Nitrite Reductases (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Nitrite (pharmacology, therapeutic use)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: